Amyloid Knock-In Mouse Model Development Service
Alzheimer's disease research is undergoing a transformative period, and are you, as a researcher, encountering difficulties in the precise modeling of this complex neurodegenerative condition? Perhaps you require more refined models for your preclinical therapeutic assessments? Creative Biolabs' Amyloid Knock-In Mouse Models furnish a powerful solution. These models offer a more faithful recapitulation of the disease's genetic underpinnings, thereby significantly accelerating your investigations.
How Our Models Can Assist Your Project?
Creative Biolabs' Amyloid Knock-In Mouse Models provide a powerful platform. They facilitate the investigation of Alzheimer's disease (AD) pathogenesis. Our models also enable the evaluation of potential therapeutic interventions. These models, by affording more physiologically relevant systems, present distinct advantages when compared to traditional transgenic models.
This enhanced relevance enables the generation of more reliable and translatable data. Key deliverables and solutions you can expect include:
- Accurate Disease Modeling: Our models faithfully replicate the genetic mutations associated with AD, leading to more accurate disease progression and pathology.
- Targeted Drug Evaluation: Utilize our models to assess the efficacy and safety of novel therapeutic compounds, with a focus on amyloid-beta (Aβ) modulation.
- Mechanistic Insights: Gain deeper understanding of the molecular mechanisms underlying AD, including Aβ production, aggregation, and downstream effects.
We invite you to explore how our expertise can facilitate your research endeavors. Request a consultation to discuss your specific needs.
Workflow:
- Required Starting Materials: To initiate a project, clients typically provide:
Specific research goals and study design.
Details of the therapeutic compound (if applicable), including dosage and administration route.
Any specific readouts or endpoints required (e.g., behavioral tests, biochemical assays).
- Final Deliverables: Clients receive:
A comprehensive study report with detailed methodology, results, and statistical analysis.
Raw and processed data in a user-friendly format.
High-quality images and histological data, where applicable.
- Estimated Timeframe:
Projected timelines for this experimental service typically fall within an 8-to-24-week window. It should be noted, however, that this duration serves principally as a guideline; the actual turnaround time is subject to variation dependent on the unique requirements of each study. The inherent complexity of the selected experimental model, the specific particulars of the study design, and the chosen evaluation criteria are primary determinants of the overall schedule. Consequently, while a standard timeframe provides an initial reference, the ultimate project duration may indeed fluctuate within this range. Factors contributing significantly to this variability include, but are not limited to, the requisite age of the animal cohort at the point of study initiation, the scale dictated by the number of distinct experimental groups, and the extent of the necessary post-experimental data processing and interpretation.
Why Choose Us?
Creative Biolabs is your trusted partner for preclinical Alzheimer's disease research. We offer several key advantages:
- Expertise: Creative Biolabs possesses deep expertise in Alzheimer's disease research and animal model development. Our team of scientists has extensive experience in generating, characterizing, and utilizing amyloid knock-in mouse models.
- Model Variety: We offer a diverse portfolio of well-characterized amyloid knock-in models, enabling you to select the most appropriate model for your specific research question.
- Customization: Creative Biolabs can generate custom knock-in models tailored to your exact research needs, including specific mutations, genetic backgrounds, and disease stages.
- Comprehensive Services: We provide a full suite of services, from study design and execution to data analysis and reporting, streamlining your research process.
- Quality and Reliability: Creative Biolabs adheres to the highest standards of animal care and experimental rigor, ensuring the quality and reliability of our data.
Experience the Advantage - Get a Quote Today
Our Amyloid Knock-In Mouse Models
Creative Biolabs offers a variety of Amyloid Knock-In Mouse Models, including the APP-SAA model, characterized by an increased Aβ42/40 ratio and early development of amyloid plaques and neuroinflammation. We also have the expertise to generate custom models with specific mutations and genetic backgrounds.
Fig.1 APP-KI mice do not show progressive cognitive impairment through 12 months of age.1
Fig.2 APPSAA but not APPWT mice show spatial learning and memory deficits at 16 months of age.1
FAQs
Q Are your Amyloid Knock-In Mouse Models suitable for long-term studies?
Q Can I use your models to study tau pathology in Alzheimer's disease?
Q What types of behavioral tests can be performed with your models?
Q Do you provide assistance with data analysis?
Q How do your Amyloid Knock-In Mouse Models compare to other models?
Related Services
In addition to Amyloid Knock-In Mouse Models, Creative Biolabs offers a range of complementary services to support your Alzheimer's disease research:
How to Contact Us
Creative Biolabs is committed to providing you with the highest quality Amyloid Knock-In Mouse Models and services to accelerate your Alzheimer's disease research. Contact our team today to discuss your project in detail and discover how we can help you achieve your research goals.
Reference
- Blackmer-Raynolds, Lisa, et al. "Longitudinal characterization reveals behavioral impairments in aged APP knock in mouse models." Scientific Reports 15.1 (2025): 4631. Distributed under Open Access license CC BY 4.0, without modification.
- iNeuMab™ Anti-TNFα BBB Shuttle Antibody (NRZP-1022-ZP4105) (Cat#: NRZP-1022-ZP4105)
- iNeuMab™ Anti-CD32b Antibody (NRP-0422-P1803) (Cat#: NRP-0422-P1803)
- iNeuMab™ Anti-EPHB2 Antibody (NRP-0422-P1220) (Cat#: NRP-0422-P1220)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1683) (Cat#: NRP-0422-P1683)
- iNeuMab™ Anti-Alpha Synuclein BBB Shuttle Antibody (NRZP-1022-ZP4050) (Cat#: NRZP-1022-ZP4050)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1760) (Cat#: NRP-0422-P1760)
- iNeu™ Human Oligodendrocyte Progenitor Cells (OPCs) (Cat#: NCL-2103-P49)
- iNeu™ Human Schwann Cell (Cat#: NCL-2103-P63)
- Mouse Glioma Cell Line GL261 (Cat#: NCL-2108P28)
- Human Brain Microvascular Endothelial Cells (Cat#: NCL-2103-P133)
- Rat Immortalized Retinal Muller Cell Line rMC-1 (Cat#: NCL-2106-S93)
- Rat Schwann Cells RSC96, Immortalized (Cat#: NCL-2108P21)
- Mouse Microglia from C57BL/6 (Cat#: NCL-21P6-082)
- Rat Muller Cell (Cat#: NCL2110P040)
- Rat Olfactory Ensheathing Cells (Cat#: NRZP-1122-ZP162)
- Human Retinal Epithelial Cell ARPE-19 (Cat#: NCL2110P069)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)